188 related articles for article (PubMed ID: 8028218)
21. 90Y-DOTA-hLL2: an agent for radioimmunotherapy of non-Hodgkin's lymphoma.
Griffiths GL; Govindan SV; Sharkey RM; Fisher DR; Goldenberg DM
J Nucl Med; 2003 Jan; 44(1):77-84. PubMed ID: 12515879
[TBL] [Abstract][Full Text] [Related]
22. Comparative serum stability of radiochelates for antibody radiopharmaceuticals.
Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK
J Nucl Med; 1987 Jan; 28(1):83-90. PubMed ID: 3794813
[TBL] [Abstract][Full Text] [Related]
23. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
[TBL] [Abstract][Full Text] [Related]
24. Relative reactivity of DTPA, immunoreactive antibody-DTPA conjugates, and nonimmunoreactive antibody-DTPA conjugates toward indium-111.
Paik CH; Hong JJ; Ebbert MA; Heald SC; Reba RC; Eckelman WC
J Nucl Med; 1985 May; 26(5):482-7. PubMed ID: 3989604
[TBL] [Abstract][Full Text] [Related]
25. Pre-clinical and clinical studies of two new bifunctional chelating agents for immunoscintigraphy with 111In-anti-CEA monoclonal antibody.
Faivre-Chauvet A; Mease RC; Chetanneau A; Bardiès M; Sai-Maurel C; Meinken GE; Srivastava SC; Chatal JF; Gestin JF
Nucl Med Commun; 1996 Sep; 17(9):781-9. PubMed ID: 8895905
[TBL] [Abstract][Full Text] [Related]
26. Serum stability of 67Cu chelates: comparison with 111In and 57Co.
Cole WC; DeNardo SJ; Meares CF; McCall MJ; DeNardo GL; Epstein AL; O'Brien HA; Moi MK
Int J Rad Appl Instrum B; 1986; 13(4):363-8. PubMed ID: 3539884
[TBL] [Abstract][Full Text] [Related]
27. A new radiochemical method to determine the stability constants of metal chelates attached to a protein.
Subramanian KM; Wolf W
J Nucl Med; 1990 Apr; 31(4):480-8. PubMed ID: 2109050
[TBL] [Abstract][Full Text] [Related]
28. Use of isothiocyanatobenzyl-DTPA derivatized monoclonal antimyosin fab for enhanced in vivo target localization.
Khaw BA; Gansow O; Brechbiel MW; O'Donnell SM; Nossiff N
J Nucl Med; 1990 Feb; 31(2):211-7. PubMed ID: 2313361
[TBL] [Abstract][Full Text] [Related]
29. A comparison of the cyclic anhydride and mixed anhydride methods for 111In-DTPA chelation to monoclonal antibodies.
Wang TS; Srivastava SC; Fawwaz RA; Giacomini P; Ferrone S; Richards P; Hardy M; Alderson PO
Nuklearmedizin; 1984 Aug; 23(4):193-5. PubMed ID: 6483630
[TBL] [Abstract][Full Text] [Related]
30. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
[TBL] [Abstract][Full Text] [Related]
31. Hepatobiliary delivery of polyaminopolycarboxylate chelates: synthesis and characterization of a cholic acid conjugate of EDTA and biodistribution and imaging studies with its indium-111 chelate.
Betebenner DA; Carney PL; Zimmer AM; Kazikiewicz JM; Brücher E; Sherry AD; Johnson DK
Bioconjug Chem; 1991; 2(2):117-23. PubMed ID: 1907855
[TBL] [Abstract][Full Text] [Related]
32. Introduction of five potentially metabolizable linking groups between 111In-cyclohexyl EDTA derivatives and F(ab')2 fragments of anti-carcinoembryonic antigen antibody--I. A new reproducible synthetic method.
Gestin JF; Faivre-Chauvet A; Mease RC; Sai-Maurel C; Thédrez P; Slinkin M; Meinken GE; Srivastava SC; Chatal JF
Nucl Med Biol; 1993 Aug; 20(6):755-62. PubMed ID: 8401376
[TBL] [Abstract][Full Text] [Related]
33. Structure-function relationships in indium-111 radioimmunoconjugates.
Brandt KD; Johnson DK
Bioconjug Chem; 1992; 3(2):118-25. PubMed ID: 1515465
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of two new bifunctional chelates for radiolabeling a parathyroid-specific monoclonal antibody with In-111.
Schwarz SW; Mathias CJ; Sun JY; Dilley WG; Wells SA; Martell AE; Welch MJ
Int J Rad Appl Instrum B; 1991; 18(5):477-81. PubMed ID: 1917517
[TBL] [Abstract][Full Text] [Related]
35. Comparison of five bifunctional chelate techniques for 90Y-labeled monoclonal antibody CO17-1A.
Washburn LC; Sun TT; Lee YC; Byrd BL; Holloway EC; Crook JE; Stubbs JB; Stabin MG; Brechbiel MW; Gansow OA
Int J Rad Appl Instrum B; 1991; 18(3):313-21. PubMed ID: 2071444
[TBL] [Abstract][Full Text] [Related]
36. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
37. Yttrium-90-labeled monoclonal antibody for therapy: labeling by a new macrocyclic bifunctional chelating agent.
Deshpande SV; DeNardo SJ; Kukis DL; Moi MK; McCall MJ; DeNardo GL; Meares CF
J Nucl Med; 1990 Apr; 31(4):473-9. PubMed ID: 2324823
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA and its conjugation with anti-Tac monoclonal antibody.
Kobayashi H; Wu C; Kim MK; Paik CH; Carrasquillo JA; Brechbiel MW
Bioconjug Chem; 1999; 10(1):103-11. PubMed ID: 9893971
[TBL] [Abstract][Full Text] [Related]
39. New chelating agent for attaching indium-111 to monoclonal antibodies: in vitro and in vivo evaluation.
Subramanian R; Colony J; Shaban S; Sidrak H; Haspel MV; Pomato N; Hanna MG; McCabe RP
Bioconjug Chem; 1992; 3(3):248-55. PubMed ID: 1520729
[TBL] [Abstract][Full Text] [Related]
40. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution.
Carrasquillo JA; White JD; Paik CH; Raubitschek A; Le N; Rotman M; Brechbiel MW; Gansow OA; Top LE; Perentesis P; Reynolds JC; Nelson DL; Waldmann TA
J Nucl Med; 1999 Feb; 40(2):268-76. PubMed ID: 10025834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
